Introduction
Dextromethorphan (DXM) (Fig. 1) is a cough suppressant, used for the relief of non-productive cough; it has a central action on the cough center in the medulla. DXM is rapidly absorbed from the gastro-intestinal tract. It is metabolized in the liver and excreted in the urine as unchanged DXM and demethylated metabolites including DXM, which has some cough-suppressant, activity. 1 The drug acts centrally to elevate the threshold for coughing. DXM is rapidly absorbed from the gastrointestinal tract, and exerts its activity within 15 to 60 min of ingestion. The duration of action after oral administration is approximately 3.0 to 8.0 h.
The official analytical method in the British Pharmacopeia for the quantitation of DXM in the bulk drug was investigated using potentiometric titrations with sodium hydroxide 1 or a chromatographic method. 2 Different spectrophotometric methods have been reported for the determination of DXM in both the bulk drug and the dosage forms. [3] [4] [5] [6] [7] [8] [9] [10] The first and second-derivative technique UV spectrophotometry, [11] [12] [13] thin-layer chromatography, New, simple and convenient potentiometric and spectrophotometric methods are described for the determination of dextromethorphan hydrobromide (DXM) in pharmaceutical preparations. The potentiometric technique is based on developing a potentiometric sensor incorporating the dextromethorphan tetrakis(p-chlorophenyl)borate ion-pair complex as an electroactive species in a plasticized PVC matrix membrane with o-nitophenyl octyl ether or dioctyl phthalate. The sensor shows a rapid near Nernstian response of over 1 × 10 -5 -1 × 10 -2 mol L -1 dextromethorphan in the pH range of 3.0 -9.0. The detection limit is 2 × 10 -6 mol L -1 DXM and the response time is instantaneous (2 s). The proposed spectrophotometric technique involves the reaction of DXM with eriochrom black T (EBT) to form an ion-associate complex. Solvent extraction is used to improve the selectivity of the method. The optimal extraction and reaction conditions have been studied, and the analytical characteristics of the method have been obtained. Linearity is obeyed in the range of 7.37 -73.7 × 10 -5 mol L -1 DXM, and the detection limit of the method is 1.29 × 10 -5 mol L -1
. The relative standard deviation (RSD) and relative error for six replicate measurements of 3.685 × 10 -4 mol L -1 are 0.672 and 0.855%, respectively. The interference effect of some excepients has also been tested. The drug contents in pharmaceutical preparations were successfully determined by the proposed methods by applying the standard-addition technique.
Keywords Dextromethorphan hydrobromide, potentiometry, spectrophotometry, pharmaceutical preparations has basic cationic nitrogen, to react with the dye (anion) at a selected acidic pH value. A highly colored ion-associate chromogen is formed, which is extracted with an organic solvent to be measured spectrophotometrically at its λmax.
The aim of the present investigation was to develop simple, reproducible and sensitive potentiometric and extractive spectrophotometric methods for the determination of DXM in pure forms and pharmaceutical preparations.
However, a novel dextromethorphan sensor was described based on using an association-complex of DXM with potassium tetrakis(pchlorophenyl)borate (PTp-ClPB) as an ion exchanger in a plasticized PVC matrix membrane.
The extractive spectrophotometric method based on the reaction of DXM with eriochrom black T (EBT) to form an ion associate was performed. Solvent extraction was used to improve the selectivity of the spectrophotometric method. The drug contents in pharmaceutical preparations were successfully determined by the proposed methods by applying the standard-addition technique.
Experimental

Reagents and chemicals
All reagents used were of analytical reagent grade unless otherwise stated, and double-distilled water was used throughout. Potassium tetrakis(p-chlorophenyl)borate (PTp-C1PB) (Fig. 2) and o-nitrophenyl octyl ether (o-NPOE) were obtained from Fluka (Buchs, Switzerland). Poly(vinylchloride) PVC (Breon S 110/OP) was obtained from BP Chemicals International (Barry, UK). An authentic dextromethorphan hydrobromide (DXM) sample (Purity 99.90%) was kindly supplied by Kahira Pharmaceuticals & Chemical Industries Co., Egypt.
The following commercial preparations were subjected to the analytical procedures: Tussilar tablets, Kahira Pharmaceuticals & Chemical Industries Co., Egypt (10 mg DXM/tablet); Tussilar drops, Kahira Pharmaceuticals & Chemical Industries Co., Egypt (1.0 g DXM/15 mL); Codiphan syrup, Nile Co. for Pharm. & Chem. Ind., Egypt (15 mg DXM/5 mL). Acetate buffer solutions of various pH values (2.45 -6.0) were prepared. 29 
Standard solutions
Stock solutions of DXM 3.685 × 10 -3 mol L -1 (0.01 g) for a calibration graph and 1 × 10 -1 mol L -1 (0.037 g) for a stoichiometry method were freshly prepared by dissolving a pure drug in double-distilled water in a 100-mL volumetric flask, and completed to the mark with water. For potentiometric studies, a stock DXM solution (1 × 10 -1 mol L -1 ) was prepared, and dilute solutions (1 × 10 -2 -1 × 10 -6 mol L -1 ) were prepared by serial dilutions, and kept in airtight brown bottles.
A stock solution (1 × 10 -3 mol L -1 ) of EBT reagent (Aldrich products) was prepared by dissolving an appropriate weight of the dye initially in 10 mL of methanol, followed by dilution in a 100-mL volumetric flask with double-distilled water to the mark.
Apparatus
All potential measurements were made at 25 ± 1 C with a PTI-15 digital pH meter using the developed potentiometric sensor in conjunction with an EIL-Type RJ 23 calomel reference electrode. A glass Ag-AgCl combination electrode (Consort, 5210 B BB5) was used for pH measurements..
A Perkin Elmer λ3B (UV-Visible) spectrophotometer with a scanning speed of 200 nm/min and a band width of 2.0 nm, equipped with 10 mm quartz cells was used for all spectrophotometric measurements. An Orion Research Model 601A/digital Ionalyzer pH meter was used for checking the pH values of acetate buffer.
Sensor construction
The preparation and assembly of a DXM sensor was performed as described previously, 30 where the constitution of the sensor was as follows: potassium tetrakis(p-chlorophenyl)borate (PTp-ClPB) (10 mg) (1.85 mass%), o-nitophenyl octyl ether or dioctyl phthalate (360 mg) (66.7 mass%) and PVC (170 mg) (31.5 mass%). The internal reference electrode was a Ag-Ag chloride wire (~0.5 mm) immersed in a 1 × 10 -2 mol L -1 DXM inner filling solution. Furthermore, the sensor was conditioned by soaking in a 1 × 10 -2 mol L -1 DXM solution for two days before use, and stored in the same solution when not in use.
The sensor was calibrated under the static mode of operation by spiking with successive aliquots of the standard solution into a 1 × 10 -6 mol L -1 solution of DXM calibrant solution. The emf values were recorded and plotted as a function of the logarithm DXM concentration. The calibration graph was used for subsequent determinations of unknown DXM concentrations.
The potentiometric selectivity coefficients ( ) k DXM,B pot were evaluated under the static mode of operation by the separate solution method 31, 32 where the potential of a cell comprising the DXM sensor and a reference electrode was measured with two separate solutions of DXM and interfering ions with the same activity (1 × 10 -2 mol L -1 ). EDXM and EB were the measured potential values for DXM and the interfering ions, respectively. The value of ( ) k DXM,B pot was calculated from the equation
where S is the slope of the calibration plot and aDXM. The activity of dextromethorphan hydrobromide ions; ZDXM and ZB the charges of the DXM and interfering ions, respectively.
Potentiometric determination of DXM in pharmaceutical preparations
For the determination of DXM in solid dosage forms, 20 tablets (tussilar, 10 mg per tablet) were accurately weighed and powdered; the required weights were dissolved in the least amount of double-distilled water. The solution was filtered into a 100-mL volumetric flask and diluted to the mark with the water. For syrup measurements, accurate volumes of the drug syrup (Codiphan) (10 mg per 5 mL) were transferred to a 100-mL volumetric flask and diluted to the mark with doubledistilled water. For drops, measurements were carried out as in the case of syrup. The potential of the sensor was measured and compared with the calibration graph.
Alternatively, the potentials were measured before and after the addition of 1.0 mL of the 1 × 10 -2 mol L -1 standard DXM solution to the test solution and the original concentration was calculated using the standard-addition method.
General procedures for spectrophotometric measurements For pure drug. Volumes of 0.2 -2.6 mL of the DXM solution (3.685 × 10 -3 mol L -1 ) containing 7.37 -95.81 × 10 -4 mol L -1 were transferred into a series of 50-mL separating funnels, followed by 2.0 mL of the reagent (1 × 10 -3 mol L -1 ) and 3.0 mL of acetate buffer of pH 2.8 being added. The volume was completed to 10 mL with double-distilled water. The formed ion-associate was extracted twice with methylene chloride with 5.0 mL portions after shaking for 2.0 min, and then allowed to stand for clear separation of the two layers. The methylene chloride layer was filtered over anhydrous sodium sulfate into a 10-mL volumetric flask, and then completed to the volume with methylene chloride. The absorbance measured at 520 nm against the corresponding reagent blank solution was similarly prepared. All measurements were carried out at room temperature (25 ± 1 C). For tablets. The contents of 20 tablets of investigated drug were crushed and powdered. An accurately weighed amount of the powder equivalent to 10 mg of DXM was dissolved in 15 mL of double-distilled water with shaking for 5.0 min and then filtered. The clear solution was diluted to 100 mL with the water in a 100-mL volumetric flask. The procedures described above for pure drug were used for the determination of DXM by applying the standard-addition technique. For syrup. A requisite volume of the drug equivalent to 15 mg was transferred into a 100-mL volumetric flask, and then diluted up to the mark with double-distilled water. The procedures described earlier for the pure drug were used for the determination of DXM by applying the standard-addition technique. For drops. The content of 5.0 bottles of drops was mixed. An accurate volume equivalent to 1.0 g of DXM was transferred into a 100-mL volumetric flask, and completed to the mark with double-distilled water. This solution was further diluted stepwise to the requisite concentration with water. The procedures described earlier were used for the determination of DXM by applying the standard-addition technique.
Stoichiometry of the reaction
Job's method of continuous variations 33 was employed; 1 × 10 -3 mol L -1 standard solutions of DXM and the reagent under consideration were used. A series of solutions were prepared in which the total volume of the drug and the reagent was kept at 2.0 mL. The reagents were mixed in various proportions, and diluted to volume in a 10-mL volumetric flask with the appropriate solvent for extraction, following the abovementioned procedures.
Results and Discussion
Potentiometric measurements
In the literature, potassium tetrakis(p-chlorophenyl)borate (PTp-C1PB) has not been mentioned as being an ion-exchanger in a potentiometric membrane sensor for determination of DXM, so far. In the present study, a dextromethorphan tetrakis(p-chlorophenyl)borate ion-pair complex was used as an electroactive material in a PVC matrix membrane. The membrane was prepared using a casting solution with the composition of 1.85 mass% PTp-C1PB ion-exchanger, 66.7 mass% o-NPOE or DOP plasticizer and 31.5 mass% PVC. The two plasticizers used have different dielectric constants. The sensor was soaked in a dextromethorphan HBr solution for two days and then tested as a DXM sensor. An evaluation of the electrochemical response characteristics of the sensor according to IUPAC recommendations 32 revealed that the sensor exhibited a near-Nernstian response over the concentration range of 5 × 10 -6 -1 × 10 -2 mol L -1 DXM (Fig. 3 ) with cationic slopes of 56.4 and 57.2 mV decade -1 for an o-NPOE and DOP-based membrane sensor, respectively ( Table 1 ). The detection limit was 2 × 10 -6 mol L -1 DXM with both plasticizers. It was found that the two plasticizers-based membrane sensor have almost the same characteristics. A least squares analysis of the data collected over 3 months gave the following relationships: for o-NPOE and DOP-based membrane sensor, respectively. The sensor exhibited constant and stable potential readings within ±0.5 mV from day to day, and the calibration slope did not change by more than 1.1 mV decade -1 over a period of 12 weeks. The response time was instantaneous (2.0 s for 1 × 10 -4 mol L -1 DXM) for both plasticizers-based membrane sensor; this is most probably due to the very rapid exchange kinetics of DXM + ions with the ion-association complex at the test solution-membrane interface. The useful life span of the sensor was 12 and 11 weeks for the o-NPOE and DOP-based membrane sensor, respectively. After that, the calibration slope and the linear range of the response gradually decreased and therefore the membranes should be renewed.
The influence of the pH on the potentiometric response of the sensor was studied using a 1 × 10 -3 mol L -1 of DXM hydrobromide solution. The pH was adjusted by the addition of dilute hydrochloric acid or sodium hydroxide, as appropriate. It is apparent from the pH-potential profile that the potential readings are fairly constant over a wide pH range of 3 -9 for both plasticized-based membrane sensor (Fig. 4) . Within this range, DXM is completely soluble, dissociated and sensed as a singly charged ion. The considerable decrease in the potential at pH values higher than 9.0 is due to the decrease in concentration of the protonated DXM where the drug starts to precipitate. At pH values lower than 3.0, the potential decreased, probably due to a change in the membrane phase.
The response of the system was examined in the presence of a number of inorganic cations and alkaloids. The potentiometric selectivity coefficients ( ) k DXM,B pot were used to evaluate the degree of interference, and it was determined using the separate solution method. 32, 34 It is well known that the selectivity of ion-exchanger complexes-based membrane sensors depends mainly on the lipophilicity of the interested ion and also on the mobilities of it within the membrane. 35 The data given in Table 2 reveal that the high selectivity of the proposed sensor towards DXM over morphine and codeine in spite of their analogy to DXM, is due to the fact that morphine and codeine have low lipophilicity as compared to DXM. This is presumably due to the presence of an OH hydrophilic group at position 6 in their skeletons. Also, the DXM sensor is highly discriminatory against ephedrine which is sometimes added to antitussive drugs. The sensor also exhibited high selectivity to DXM over inorganic cations, may be due to their low lipophilicity and small ionic size, and consequently the low mobilities and permeabilities inside the membrane. Pharmaceutical excipients and diluents commonly used in drug formulations (e.g. glucose, lactose, maltose, mannitol, starch, talc powder and magnesium stearate) at concentrations as high as a 100 -500 fold molar excess over DXM did not interfere. Furthermore, the DOP-based membrane sensor is generally slightly more selective than the o-NPOEbased membrane one. Therefore it will be used in potentiometric application studies throughout. On the other hand, the reliability of the sensor for the determination of DXM was assessed by determining 2.73 -6.82 × 10 -6 mol L -1 standard DXM solutions using the calibration graph method with the DOP-based membrane sensor. The results showed an average recovery of 100% and a relative standard deviation of 0.4% (n = 5).
Spectrophotometric measurements
Under the optimum conditions of the pH, time, temperature and sequence of the addition of reagents, some basic drugs with anionic dyes forming ion-associate complexes, which are often colored and extracted into an organic solvent to be subsequently measured colorimetrically. The absorption spectra of the ionassociates formed between DXM and the reagent were measured at 350 -600 nm against the corresponding blank solution. The extracts showed maximum absorbance at 520 nm using the EBT reagent extracted into methylene chloride. Various parameters affecting the reaction development were studied.
Effect of pH
In order to establish the optimum pH value for each ionassociate formed, each reagent under consideration was allowed to react with DXM in acetate buffer solutions at pH values ranging from 2.45 to 6.0. The formed ion-associate was extracted with methylene chloride in order to measure the absorbance intensity at λmax. The highest absorbance values were obtained at pH 2.8 (Fig. 5) . Furthermore, the amount of buffer added was varied from 1.0 to 5.0 mL, and the optimum amount was found to be 3.0 mL for all reagents to give the highest absorbance values.
Choice of the organic solvent
The polarity of the solvent affects both the extraction efficiency and the absorbance intensity. The results using different extraction solvents (chloroform, methylene chloride, 1,2 dichloroethane, benzene, toluene and carbon tetrachloride) indicated that methylene chloride is the optimum due to their higher molar absorptivity values and considerably lower extraction ability of the reagent blank.
Effect of the extraction time and number of extractions
The shaking time required for complete colour development of an ion-associate formed between drugs and dyes at room temperature was investigated. It was observed that 5.0 min is quite sufficient to obtain the maximum color intensity, before extraction. After adding the extracting solvent, the optimum shaking time is 2.0 min. Complete extraction was attained by double extraction twice with methylene chloride using 5.0 mL portions. The intensity of the ion-associates extraction was found to be stable for more than 6.0 h at room temperature (25 ± 1 C).
Effect of the reagent volume
When various volumes of a 1 × 10 -3 mol L -1 reagent were added to a fixed concentration of DXM (3.685 × 10 -4 mol L -1 ), 2.0 mL of the reagent solution was found to sufficient for producing the maximum and reproducible color intensity. Large volumes of the reagent did not affect the color intensity. The most favorable addition sequence was the drug-reagent, then the buffer to obtain the least time for developing the maximum absorbance; all other sequences needed longer times, and gave a lower absorbance.
Composition of the ion-associate complex
The composition of the ion-associate complexes was established by Job's method of continuous variation. The results indicated that the stoichiometric ratio of the drug to dye was found to be 1:1 in the formed ion-associate (Fig. 6) . The suggested structure of the ion-associate complex is represented as shown in Fig. 7 .
Interferences
To test the efficiency and the selectivity of the proposed analytical methods to pharmaceutical preparations, a systematic study under the optimum experimental conditions was made concerning the effect of the additives and excipients (e.g. lactose, glucose, fructose, calcium hydrogen phosphate, magnesium stearate and starch) that are usually present in pharmaceutical preparations. The criterion of interference was an error of not more than the 3.0% in the absorbance. Experiments showed that there was no interference from the additives and the excipients for the examined method.
Method validations
Under the experimental conditions described above, the calibration graphs for the five reagents were constructed by plotting the absorbance versus the concentration in mol L -1 . Conformity with Beer's law was evident in the concentration ranges cited in Table 3 . The regression equation, intercept, slope, correlation coefficient for the calibration data, the mean molar absorptivity (ε) and Sandell sensitivity (SS) were calculated, and are presented in Table 3 . For more accurate results, the Ringbom optimum concentration range (which was determined by plotting log[C] mol L -1 against the percent transmittance and the linear portion of the S-shaped curve and gave an accurate range of the analysis) was calculated as shown in Table 3 . The % recoveries of the pure drug using the proposed method compared with that given by the reference method 1 are illustrated in Table 4 . The validity of the proposed methods was evaluated by statistical analysis 36 between the obtained results and that of the reference method (using potentiometric titrations with sodium hydroxide). 1 Regarding the calculated student's t-test and the variance ratio F-test (Table 4) , there was no significant difference between the proposed and the reference method regarding the accuracy and precision.
Accuracy and precision
In order to determine the accuracy and the precision of the spectrophotometric method, solutions containing three different concentrations of DXM were prepared and analyzed. The analytical results obtained from this investigation are summarized in Table 5 . The relative standard deviations and the percentage range of the error at the 95% confidence level were calculated. The results can be considered to be satisfactory, at least for the level of concentrations examined.
Analytical applications
The validity of the proposed procedures was tested in order to determine DXM in dosage forms. The results recorded in Table 4 were compared statistically with the official method. The student's t-and F-values obtained at the 95% confidence level did not exceed the theoretical tabulated value indicating no significant difference between the proposed and official methods. For further confirmation, the standard-addition technique was applied to test the reliability and recovery of the proposed procedures, in which variable amounts of DXM were added to the previously analyzed portion of pharmaceutical preparations (Table 6 ).
Conclusions
The proposed potentiometric and spectrophotometric methods were successfully utilized for the determination of dextromethorphan hydrobromide in its pure form, and pharmaceutical preparations. They proved to be sensitive, simple, accurate, precise, and less time consuming in handling. 
